Baillie Gifford & CO Sana Biotechnology, Inc. Put Options Transaction History
Baillie Gifford & CO
- $126 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SANA
# of Institutions
168Shares Held
121MCall Options Held
811KPut Options Held
1.02M-
Flagship Pioneering Inc. Cambridge, MA25MShares$91.5 Million16.32% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$47.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11MShares$40.4 Million0.0% of portfolio
-
Canada Pension Plan Investment Board Toronto Ontario, A610.2MShares$37.2 Million0.06% of portfolio
-
State Street Corp Boston, MA6.36MShares$23.3 Million0.0% of portfolio
About Sana Biotechnology, Inc.
- Ticker SANA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 190,232,000
- Market Cap $696M
- Description
- Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...